abstract |
The present invention relates to compounds of formula (I) wherein A, R 1 to R 5 and G are as defined in the description and claims, and pharmaceutically acceptable salts thereof. The invention further relates to pharmaceutical compositions comprising such compounds, methods for their preparation, and their use for the treatment and / or prevention of diseases associated with modulation of SST receptor subtype 5. |